Shareholders have the ultimate authority over the company and exercise their right to make decisions regarding Novo Nordisk A/S at the General Meeting of the Company.

General Meetings are called with a notice of three to five weeks. In the InvestorPortal and on this website you will find a form for proxies and voting by correspondence allowing each shareholder to vote on each agenda item. Shareholders may ask questions before the Extraordinary General Meeting and shareholders having registered for the Extraordinary General Meeting may ask questions in writing during the meeting through the Computershare Meeting Services application.

The Extraordinary General Meeting will be held to elect new members of the Board of Directors of Novo Nordisk A/S.

The Extraordinary General Meeting is held in English with simultaneous interpretation to Danish. Shareholders may submit questions in Danish, should they so prefer.